Currently out of the existing stock ratings of Elliot Wilbur, 19 are a HOLD (16.67%), 95 are a BUY (83.33%).

Elliot Wilbur

Work Performance Price Targets & Ratings Chart

Analyst Elliot Wilbur, carries an average stock price target met ratio of 56.35% that have a potential upside of 37.6% achieved within 570 days. Previously, Elliot Wilbur worked at RAYMOND JAMES.

Elliot Wilbur’s has documented 207 price targets and ratings displayed on 26 stocks. The coverage was on Healthcare, Financial Services sectors.

Most recent stock forecast was given on ANIP, ANI Pharmaceuticals at 09-May-2023.

Wall Street Analyst Elliot Wilbur

Analyst best performing recommendations are on AMRX (AMNEAL PHARMACEUTICALS, COMMON STOCK).
The best stock recommendation documented was for AMRX (AMNEAL PHARMACEUTICALS, COMMON STOCK) at 11/7/2019. The price target of $4 was fulfilled within 26 days with a profit of $1.35 (50.94%) receiving and performance score of 19.59.

Average potential price target upside

of $65.55 (76.11%) on SLGL (SOL GEL TECHNOLOGIES LTD).
of $58.64 (63.4%) on VRTS (VIRTUS INVESTMENT PARTNERS).
of $44.92 (33.04%) on AGN (ALLERGAN PLC).

ADMP Adamis Pharma AGN Allergan plc AKRX Akorn ANIP ANI Pharmaceuticals ATRS Antares Pharma FLXN Flexion Therapeutics MNK Mallinckrodt plc MYL Viatris PLXP PLx Pharma PRGO Perrigo Company PLC PTX Pernix Therapeutics Holdings SGNT Sagent Pharmaceuticals SLGL Sol Gel Technologies Ltd TEVA Teva Pharma Industries Ltd ADR ADMA ADMA Biologics AMRX Amneal Pharmaceuticals, Common Stock CVET Covetrus PETQ PetIQ PYPD PolyPid VTRS Viatris ZTS Zoetis AERI Aerie Pharmaceuticals AMPH Amphastar P OGN Organon DERM Journey Medical Corp VRTS Virtus Investment Partners

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Jason Kolbert (DAWSON JAMES)